COVID-19 vaccine-related axillary edema in breast imaging setting
- PMID: 34976267
- PMCID: PMC8712278
- DOI: 10.1016/j.radcr.2021.11.075
COVID-19 vaccine-related axillary edema in breast imaging setting
Erratum in
-
Erratum regarding missing patient consent statements in previously published articles.Radiol Case Rep. 2023 Jan 24;18(3):1389-1390. doi: 10.1016/j.radcr.2023.01.014. eCollection 2023 Mar. Radiol Case Rep. 2023. PMID: 36818993 Free PMC article.
Abstract
Worldwide, many vaccines have been developed in response to the COVID-19 pandemic. Unilateral reactive axillary adenopathy related to the COVID-19 vaccine is a well-known occurrence. In addition, axillary edema has also been observed following COVID-19 vaccinations in patients undergoing breast MRI, and radiologists need to be aware of this possibility to avoid performing unnecessary work-up that can be costly to the health care system and be stressful for patients.
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures
References
-
- Newfield L, Naschitz JE, Yeshurun D. BCG-induced axillary lymph-adenitis in the adult. Harefuah. 1990;119(7-8):199–200. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
